Journal
STROKE
Volume 50, Issue 5, Pages 1232-1239Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/STROKEAHA.118.023620
Keywords
brain; cytokine; inflammasome; inflammation; interleukin
Categories
Funding
- Medical Research Council [MR/N003586/1, MC_PC_16033]
- Wellcome Trust [106898/A/15/Z]
- MRC [MR/N003586/1, MC_PC_16033] Funding Source: UKRI
Ask authors/readers for more resources
Background and Purpose-A major process contributing to cell death in the ischemic brain is inflammation. Inflammasomes are multimolecular protein complexes that drive inflammation through activation of proinflammatory cytokines, such as IL (interleukin)-1 beta. Preclinical evidence suggests that IL-1 beta contributes to a worsening of ischemic brain injury. Methods-Using a mouse middle cerebral artery thrombosis model, we examined the inflammatory response after stroke and the contribution of the NLRP3 (NACHT, LRR and PYD domains-containing protein 3) inflammasome to ischemic injury. Results-There was a marked inflammatory response after stroke characterized by increased expression of proinflammatory cytokines and NLRP3 and by recruitment of leukocytes to the injured tissue. Targeting NLRP3 with the inhibitor MCC950, or using mice in which NLRP3 was knocked out, had no effect on the extent of injury caused by stroke. Conclusions-These data suggest that the NLRP3 pathway does not contribute to the inflammation exacerbating ischemic brain damage, contradicting several recent reports to the contrary. Visual Overview-An online visual overview is available for this article.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available